S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.16%) $0.928
USD/NOK
(0.26%) $10.87
USD/GBP
(0.00%) $0.792
USD/RUB
(-0.18%) $92.41

Realtime updates for Sesen Bio Inc [SESN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated7 Mar 2023 @ 16:00

7.29% $ 0.629

Live Chart Being Loaded With Signals

Commentary (7 Mar 2023 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer...

Stats
Today's Volume 1.78M
Average Volume 1.24M
Market Cap 127.96M
EPS $-53.13 ( 2023-09-29 )
Last Dividend $0.360 ( 2023-03-06 )
Next Dividend $0 ( N/A )
P/E -6.29
ATR14 $0.0360 (5.73%)
Insider Trading
Date Person Action Amount type
2023-06-06 Kelly Steven Buy 600 000 Stock Option (Right to Buy)
2023-06-06 Zweifach Sanford S Buy 38 700 Stock Option (Right to Buy)
2023-06-06 Morris Richard Steven Buy 238 000 Stock Option (Right to Buy)
2023-06-06 Torok Michael Buy 38 700 Stock Option (Right to Buy)
2023-06-06 Klichinsky Michael Buy 238 000 Stock Option (Right to Buy)
INSIDER POWER
76.65
Last 87 transactions
Buy: 18 644 112 | Sell: 1 508 721

Volume Correlation

Long: 0.00 (neutral)
Short: -0.48 (neutral)
Signal:(57.604) Neutral

Sesen Bio Inc Correlation

10 Most Positive Correlations
BOCH0.945
SHSP0.905
DYNT0.846
SGC0.836
MMAC0.83
WWD0.829
SYKE0.826
LIVE0.825
DGLY0.823
ECOR0.817
10 Most Negative Correlations
GAINL-0.898
APOP-0.887
TDAC-0.884
RMRM-0.88
ISNS-0.872
SVOK-0.829
VERA-0.822
AHPI-0.801

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sesen Bio Inc Correlation - Currency/Commodity

The country flag -0.57
( weak negative )
The country flag -0.35
( neutral )
The country flag 0.00
( neutral )
The country flag -0.46
( neutral )
The country flag 0.14
( neutral )
The country flag 0.62
( weak )

Sesen Bio Inc Financials

Annual 2022
Revenue: $40.00M
Gross Profit: $40.00M (100.00 %)
EPS: $-1.990
Q3 2023
Revenue: $3.83M
Gross Profit: $3.83M (100.00 %)
EPS: $-0.530
Q2 2023
Revenue: $3.56M
Gross Profit: $3.56M (100.00 %)
EPS: $-0.490
Q1 2023
Revenue: $3.24M
Gross Profit: $3.24M (100.00 %)
EPS: $-1.930

Financial Reports:

No articles found.

Sesen Bio Inc Dividends

(Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.360
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Sesen Bio Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 5.13 - average (38.17%) | Divividend Growth Potential Score: 0.276 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.360 2023-03-06
Last Dividend $0.360 2023-03-06
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.360 --
Avg. Dividend % Per Year 18.77% --
Score 4.82 --
Div. Sustainability Score 5.13
Div.Growth Potential Score 0.276
Div. Directional Score 2.70 --
Next Divdend (Est)
(2024-03-29)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
4.82
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2023 $0.360 56.30%
2024 $0 0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1.6051.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.7611.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.9101.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM7.530.80010.008.00[1 - 3]
quickRatioTTM7.270.80010.008.00[0.8 - 2.5]
cashRatioTTM6.421.50010.0010.00[0.2 - 2]
debtRatioTTM0.0257-1.5009.57-10.00[0 - 0.6]
interestCoverageTTM11.341.0006.916.91[3 - 30]
operatingCashFlowPerShareTTM0.01992.009.9910.00[0 - 30]
freeCashFlowPerShareTTM0.01662.009.9910.00[0 - 20]
debtEquityRatioTTM0.0593-1.5009.76-10.00[0 - 2.5]
grossProfitMarginTTM1.0001.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM-1.5101.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2921.0009.499.49[0.2 - 2]
assetTurnoverTTM0.4740.800-0.172-0.138[0.5 - 2]
Total Score5.13

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.3121.000-0.1330[1 - 100]
returnOnEquityTTM-0.9102.50-7.21-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.01662.009.9910.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.01992.009.9910.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM0.01581.000-2.100[0.1 - 0.5]
Total Score0.276

Sesen Bio Inc

Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators